Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
House Bill 2401
116th Congress(2019-2020)
American Cures Act
Introduced
Introduced
Introduced in House on Apr 30, 2019
Overview
Text
Introduced in House 
Apr 30, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in House(Apr 30, 2019)
Apr 30, 2019
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
H. R. 2401 (Introduced-in-House)


116th CONGRESS
1st Session
H. R. 2401


To prioritize funding for an expanded and sustained national investment in biomedical research.

IN THE HOUSE OF REPRESENTATIVES

April 30, 2019

Ms. Underwood (for herself and Mr. Foster) introduced the following bill; which was referred to the Committee on the Budget, and in addition to the Committees on Energy and Commerce, Armed Services, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To prioritize funding for an expanded and sustained national investment in biomedical research.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “American Cures Act”.

SEC. 2. Cap adjustment.

(a) In general.—Section 251(b)(2) of the Balanced Budget and Emergency Deficit Control Act of 1985 (2 U.S.C. 901(b)(2)) is amended—

(1) by redesignating subparagraphs (D), (E), and (F) as subparagraphs (E), (F), and (G), respectively; and

(2) by inserting after subparagraph (C), the following:

“(D) BIOMEDICAL RESEARCH.—

“(i) NATIONAL INSTITUTES OF HEALTH.—If a bill or joint resolution making appropriations for a fiscal year is enacted that specifies amounts for the National Institutes of Health at the Department of Health and Human Services, then the adjustments for that fiscal year shall be the amount of additional new budget authority provided in that Act for such programs for that fiscal year, but shall not exceed—

“(I) for fiscal year 2020, $2,737,000,000 in additional new budget authority;

“(II) for fiscal year 2021, $5,666,000,000 in additional new budget authority;

“(III) for fiscal year 2022, $8,800,000,000 in additional new budget authority;

“(IV) for fiscal year 2023, $12,153,000,000 in additional new budget authority; and

“(V) for fiscal year 2024, $15,741,000,000 in additional new budget authority.

“(ii) CENTERS FOR DISEASE CONTROL AND PREVENTION.—If a bill or joint resolution making appropriations for a fiscal year is enacted that specifies amounts for the Centers for Disease Control and Prevention at the Department of Health and Human Services, then the adjustments for that fiscal year shall be the amount of additional new budget authority provided in that Act for such programs for that fiscal year, but shall not exceed—

“(I) for fiscal year 2020, $511,000,000 in additional new budget authority;

“(II) for fiscal year 2021, $1,057,000,000 in additional new budget authority;

“(III) for fiscal year 2022, $1,642,000,000 in additional new budget authority;

“(IV) for fiscal year 2023, $2,268,000,000 in additional new budget authority; and

“(V) for fiscal year 2024, $2,938,000,000 in additional new budget authority.

“(iii) DEPARTMENT OF DEFENSE HEALTH PROGRAM.—If a bill or joint resolution making appropriations for a fiscal year is enacted that specifies amounts for the Department of Defense health program, then the adjustments for that fiscal year shall be the amount of additional new budget authority provided in that Act for such programs for that fiscal year, but shall not exceed—

“(I) for fiscal year 2020, $167,510,000 in additional new budget authority;

“(II) for fiscal year 2021, $346,745,700 in additional new budget authority;

“(III) for fiscal year 2022, $538,527,899 in additional new budget authority;

“(IV) for fiscal year 2023, $743,734,852 in additional new budget authority; and

“(V) for fiscal year 2024, $963,306,292 in additional new budget authority.

“(iv) MEDICAL AND PROSTHETICS RESEARCH PROGRAM OF THE DEPARTMENT OF VETERANS AFFAIRS.—If a bill or joint resolution making appropriations for a fiscal year is enacted that specifies amounts for the medical and prosthetics research program of the Department of Veterans Affairs, then the adjustments for that fiscal year shall be the amount of additional new budget authority provided in that Act for such programs for that fiscal year, but shall not exceed—

“(I) for fiscal year 2020, $54,530,000 in additional new budget authority;

“(II) for fiscal year 2021, $58,350,000 in additional new budget authority;

“(III) for fiscal year 2022, $62,440,000 in additional new budget authority;

“(IV) for fiscal year 2023, $66,810,000 in additional new budget authority; and

“(V) for fiscal year 2024, $71,490,000 in additional new budget authority.

“(v) DEFINITIONS.—As used in this subparagraph:

“(I) ADDITIONAL NEW BUDGET AUTHORITY.—The term ‘additional new budget authority’ means—

“(aa) with respect to the National Institutes of Health, the amount provided for a fiscal year, in excess of the amount provided in fiscal year 2019, in an appropriation Act and specified to support the National Institutes of Health;

“(bb) with respect to the Centers for Disease Control and Prevention, the amount provided for a fiscal year, in excess of the amount provided in fiscal year 2019, in an appropriation Act and specified to support the Centers for Disease Control and Prevention;

“(cc) with respect to the Department of Defense health program, the amount provided for a fiscal year, in excess of the amount provided in fiscal year 2019, in an appropriation Act and specified to support the Department of Defense health program; and

“(dd) with respect to the medical and prosthetics research program of the Department of Veterans Affairs, the amount provided for a fiscal year, in excess of the amount provided in fiscal year 2019, in an appropriation Act and specified to support the medical and prosthetics research program of the Department of Veterans Affairs.

“(II) CENTERS FOR DISEASE CONTROL AND PREVENTION.—The term ‘Centers for Disease Control and Prevention’ means the appropriations accounts that support the various institutes, offices, and centers that make up the Centers for Disease Control and Prevention.

“(III) DEPARTMENT OF DEFENSE HEALTH PROGRAM.—The term ‘Department of Defense health program’ means the appropriations accounts that support the various institutes, offices, and centers that make up the Department of Defense health program.

“(IV) MEDICAL AND PROSTHETICS RESEARCH PROGRAM OF THE DEPARTMENT OF VETERANS AFFAIRS.—The term ‘medical and prosthetics research program of the Department of Veterans Affairs’ means the appropriations accounts that support the various institutes, offices, and centers that make up the medical and prosthetics research program of the Department of Veterans Affairs.

“(V) NATIONAL INSTITUTES OF HEALTH.—The term ‘National Institutes of Health’ means the appropriations accounts that support the various institutes, offices, and centers that make up the National Institutes of Health.”.

(b) Funding.—There are hereby authorized to be appropriated—

(1) for the National Institutes of Health, the amounts provided for under clause (i) of such section 251(b)(2)(D) in each of fiscal years 2020 through 2024, and such sums as may be necessary for each subsequent fiscal year;

(2) for the Secretary of Health and Human Services, acting through the Centers for Disease Control and Prevention, the amounts provided for under clause (ii) of such section 251(b)(2)(D) in each of fiscal years 2020 through 2024, and such sums as may be necessary for each subsequent fiscal year;

(3) for the Department of Defense health program, the amounts provided for under clause (iii) of such section 251(b)(2)(D) in each of fiscal years 2020 through 2024, and such sums as may be necessary for each subsequent fiscal year; and

(4) for the medical and prosthetics research program of the Department of Veterans Affairs, the amounts provided for under clause (iv) of such section 251(b)(2)(D) in each of fiscal years 2020 through 2024, and such sums as may be necessary for each subsequent fiscal year.

(c) Minimum continued funding requirement.—Amounts appropriated for each of the programs and agencies described in section 251(b)(2)(D) of the Balanced Budget and Emergency Deficit Control Act of 1985 (as added by subsection (a)) for each of fiscal years 2020 through 2024, and each subsequent fiscal year, shall not be less than the amounts appropriated for such programs and agencies for fiscal year 2019.

(d) Exemption of certain appropriations from sequestration.—

(1) IN GENERAL.—Section 255(g)(1)(A) of the Balanced Budget and Emergency Deficit Control Act (2 U.S.C. 905(g)(1)(A)) is amended by inserting after “Advances to the Unemployment Trust Fund and Other Funds (16–0327–0–1–600).” the following:

“ Appropriations under the American Cures Act”..”.

(2) APPLICABILITY.—The amendment made by this section shall apply to any sequestration order issued under the Balanced Budget and Emergency Deficit Control Act of 1985 (2 U.S.C. 900 et seq.) on or after the date of enactment of this Act.